Healthy volunteers help test new TB drug's safety with common medications
NCT ID NCT07542847
First seen May 12, 2026 · Last updated May 14, 2026 · Updated 2 times
Summary
This study looked at how a new tuberculosis drug, OPC-167832, interacts with other medicines in 24 healthy adults. Participants took the drug alone and with either a common antifungal or seizure medication to see how their bodies processed it. The goal was to check for safety and measure drug levels in the blood, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON plc
Lenexa, Kansas, 66219, United States
Conditions
Explore the condition pages connected to this study.